Scientists at NTU Singapore have developed a synthetic peptide that can make multidrug-resistant bacteria sensitive to antibiotics again when used together with traditional antibiotics, offering hope for the prospect of a combination treatment strategy to tackle certain antibiotic-tolerant infections. On its own, the synthetic antimicrobial peptide can also kill bacteria that have grown resistant to antibiotics.
- ESMO 2020: Breast cancer drug set to transform prostate cancer treatment
- No benefit for post-operative radiotherapy in non-small-cell lung cancer
- First new drug in years reduces recurrence in high risk HR+ early breast cancer
- New first-line treatment option for metastatic kidney cancer
- UC study sheds light on cancer treatment, COVID-19